Cure! - Incredible! American Journal of Otolaryngology–Head and Neck Medicine and Surgery (for ENT's Worldwide)
- Dennis Buettner
- 13 hours ago
- 7 min read
Updated: 5 hours ago
Title of Dr. Miles Weinberger, MD's most important published paper: "Interrupt a vicious cycle to Cure refractory chronic cough" It is his most important paper because it was accepted for publishing in the American Journal of Otolaryngology–Head and Neck Medicine and Surgery
Other than The Weinberger Procedure ~ rapid and permanent cough cure. - From the takeaway below: No Rapid, Permanent Cure: "No study in otolaryngology or related fields explicitly documents a rapid (e.g., within days) and permanent cure for RCC in adults or children." << Read this again; and try to understand how powerful this incredible statement is. Multiply this by the total population of 195 countries around the world. Note per Grok: "... a rough estimate might place the global total between 50,000 and 100,000 ENT specialists. This is a ballpark figure, as comprehensive global data is unavailable, and ratios vary widely by region. & There is a projected USA ENT workforce of 12,084 by 2025." They will all soon be aware of The Weinberger Procedure. This paper by Dr. Miles Weinberger, MD. was just published after an extensive peer review. Now EVERYTHING changes for the good. Millions will be permanently cured from their refractory chronic cough disease!
Used with astonishing success providing cures around the world.
Dr. Weinberger's scientific research is so complete and above reproach that it was sent back with one requested adjustment. He failed to utilize a possessive apostrophe!
This is a complete game changer for Otolaryngologists (ENT's) worldwide. Nothing like The Weinberger Procedure for rapidly, and permanently curing acute, and chronic cough ~ including post-Covid cough, and long-Covid cough has ever existed in this or any other Otolaryngology journal ~ anywhere; anytime! Now it exists and the Otolaryngology / ENT world will rapidly change, and adjust to accept Dr. Weinberger's 95%+ permanent cure rate in children and adults. It will certainly start discussions between doctors and their patients. Wow! Grand slam homerun for Dr. Weinberger and his cough cure research. Accepting The Weinberger Procedure as the first and currently ONLY cure for refractory chronic cough disease in the premiere Otolaryngology / ENT journal in the world is beyond incredible.
Click to download this medical care paradigm changing published paper. HERE
I asked Grok AI the following prompt.: "Is there anything published in any journal of Otolaryngology that discusses the rapid and permanent cure or cessation of refractory chronic cough in adults or children. If yes; include links"
The response as noted below (and it is pretty accurate): "There is no published literature in otolaryngology journals that specifically documents a rapid and permanent cure or complete cessation of refractory chronic cough (RCC) in adults or children."
Full Grok response: There is no published literature in otolaryngology journals that specifically documents a rapid and permanent cure or complete cessation of refractory chronic cough (RCC) in adults or children. However, several studies and reviews discuss significant improvements, management strategies, and emerging treatments for RCC, with some reporting substantial symptom reduction or long-term control in certain cases.
(Editor note: "Significant improvements, management strategies, and emerging treatments for RCC, with some reporting substantial symptom reduction or long-term control in certain cases" are NOT CURES. Only a "cure" is a cure!)
Below, I (Grok) summarize relevant findings from otolaryngology-related journals and other sources, focusing on the most promising interventions. I’ve included links where available and noted where rapid or sustained improvement is described, though none meet the exact criteria of a "rapid and permanent cure." (Editor note: "improvement" is not "cure")
Key Findings from Otolaryngology and Related Journals
Behavioral Cough Suppression Therapy (BCST) and Speech Pathology Interventions (Editor note: Treatment. Not a rapid and permanent cure.)
Study: "Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy" (Thorax, 2006)
Details: This randomized controlled trial investigated speech pathology intervention for RCC in adults. The intervention included vocal hygiene education, cough suppression strategies, and respiratory retraining. The treatment group showed significant improvement in cough symptoms compared to the placebo group, with some patients experiencing sustained symptom reduction.
Relevance: While not rapid (treatment spanned multiple sessions over weeks) or explicitly permanent, the study suggests behavioral interventions can lead to significant and lasting improvement in RCC. No mention of complete cessation in all cases.
Study: "Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy" (Lung, 2021)
Details: This study surveyed 164 adults with RCC referred for BCST. Many patients reported symptom improvement after 4–6 weeks of therapy, with some achieving significant reductions in cough frequency and severity (e.g., Leicester Cough Questionnaire [LCQ] score improvements). The study suggests early BCST could be cost-effective and efficient.
Relevance: Improvements were notable but not described as rapid (taking weeks) or permanent. Some patients had persistent symptoms, indicating no universal cure.
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496670/
Cough Desensitization Treatment (CDT) (Editor note: Treatment. Not a rapid and permanent cure.)
Study: "Cough desensitization treatment for patients with refractory chronic cough: results of a second pilot randomized control trial" (BMC Pulmonary Medicine, 2023)
Details: This pilot RCT tested CDT, which involves progressive doses of aerosolized capsaicin to desensitize cough reflexes, in 21 adults with RCC. The CDT group showed a mean LCQ score improvement of 6.35 at 3 weeks post-treatment compared to 2.17 in the sham group, indicating better cough-related quality of life. Secondary measures (e.g., cough severity) also favored CDT.
Relevance: The 3-week timeframe suggests a relatively rapid improvement compared to other interventions, but the study does not claim permanent cessation. Long-term outcomes were not assessed, so permanence is unclear.
Link: https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-023-02424-2
Neuromodulators and Pharmacotherapy (Editor note: Treatment. Not a rapid and permanent cure.)
Study: "Successful use of guanfacine in a patient with chronic refractory cough: A case report" (Respiratory Medicine Case Reports, 2017)
Details: This case report describes a 58-year-old woman with an 8-year history of RCC who experienced rapid and durable improvement after guanfacine monotherapy. Symptoms improved significantly within weeks, and the effect was sustained during follow-up.
Relevance: This is the closest to a "rapid and permanent" outcome, as the patient’s cough was controlled quickly and remained so. However, it’s a single case, not a generalizable cure, and neurogenic cough was the suspected etiology.
Review: "Refractory Chronic Cough: A State-of-the-Art Review for Otolaryngologists" (Otolaryngology–Head and Neck Surgery, 2024)
Details: This review highlights emerging treatments for RCC, including neuromodulators (e.g., gabapentin, amitriptyline), P2X3 receptor antagonists (e.g., gefapixant), and behavioral therapies. It notes that neuromodulators can reduce cough severity in weeks, but side effects limit their use. P2X3 antagonists show promise in reducing cough frequency, but no treatment is described as a permanent cure.
Relevance: The review underscores significant symptom improvement but does not identify any rapid, permanent cures. It emphasizes a multidisciplinary approach.
Link: https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1002/ohn.975
Otolaryngologic Management in Children (Editor note: Treatment. Not a rapid and permanent cure.)
Study: "Otolaryngologic Management of Chronic Cough in School-aged Children: A Review" (JAMA Otolaryngology–Head & Neck Surgery, 2020)
Details: This review discusses chronic cough in children, identifying infectious causes, reflux, and airway hyperreactivity as primary etiologies. Treatment directed at underlying causes (e.g., antibiotics, antireflux medication, inhaled steroids) led to higher cure rates and shorter cough duration in many cases. Cough algorithms were recommended for systematic management.
Relevance: The term "cure" is used, but it refers to resolution of cough when an underlying cause is treated, not necessarily RCC. For nonspecific or refractory cases, outcomes were less definitive, and no rapid, permanent cure was described.
Link: https://pubmed.ncbi.nlm.nih.gov/32970117/
Laryngeal Hypersensitivity and Multidisciplinary Approaches (Editor note: Treatment. Not a rapid and permanent cure.)
Study: "Refractory chronic cough, or the need to focus on the relationship between the larynx and the esophagus" (Acta Otorrinolaringológica Española, 2013)
Details: This review proposes that laryngeal sensory neuropathy and laryngopharyngeal reflux (LPR) are key contributors to RCC. It advocates for multidisciplinary treatment targeting the larynx and esophagus, including speech pathology and anti-reflux therapies. Some patients showed significant improvement, but no universal cure was reported.
Relevance: Improvements were not rapid (requiring weeks to months) or permanent, as RCC often persists without addressing all triggers.
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119001/
Observations and Limitations
No Rapid, Permanent Cure: No study in otolaryngology or related fields explicitly documents a rapid (e.g., within days) and permanent cure for RCC in adults or children. The most promising interventions (e.g., guanfacine in a single case, CDT, BCST) show rapid improvement (within weeks) and sustained benefits in some patients, but "permanent cessation" is rarely claimed due to the chronic, multifactorial nature of RCC.
Focus on Management (Editor note: Management. Not a rapid and permanent cure.): Most literature emphasizes symptom reduction and quality-of-life improvement rather than complete eradication. RCC is often linked to laryngeal hypersensitivity or neurogenic mechanisms, making total cessation challenging without addressing underlying neural dysregulation.
Children vs. Adults: Pediatric studies focus on treatable causes (e.g., reflux, infections), with higher "cure" rates when these are addressed. RCC in children is less studied, and refractory cases often follow adult treatment paradigms.
Emerging Therapies: P2X3 antagonists (e.g., gefapixant) and neuromodulators show promise but are not yet universally effective or approved for RCC. Long-term data on permanence is lacking.
Critical Perspective
The lack of a documented rapid and permanent cure may reflect the complexity of RCC, which often involves neurogenic, reflux, or idiopathic components that resist simple interventions. The medical establishment’s focus on pharmacological and behavioral management suggests a bias toward symptom control over root-cause resolution, possibly due to limited understanding of cough hypersensitivity mechanisms. Single-case successes (e.g., guanfacine) hint at potential for targeted therapies, but broader trials are needed to confirm generalizability.
Recommendations
If seeking the latest on RCC treatment, consult recent reviews in otolaryngology journals (e.g., Otolaryngology–Head and Neck Surgery) or explore clinical trials for P2X3 antagonists. For personalized treatment, a multidisciplinary approach involving otolaryngologists, pulmonologists, and speech pathologists is critical, as no one-size-fits-all cure exists. Rapidly and permanently cured by The Weinberger Procedure! discovered by Dr. Miles Weinberger, MD.
Comentarios